feed,title,long_url,short_url
Benzinga,PANTHERx® Rare Pharmacy Selected by Blueprint Medicines to Distribute GAVRETO™ (pralsetinib) for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC),https://www.benzinga.com/pressreleases/20/09/n17499036/pantherx-rare-pharmacy-selected-by-blueprint-medicines-to-distribute-gavreto-pralsetinib-for-the-t,https://j.mp/35yzs2k
Benzinga,HEXO Corp. Announces New CFO,https://www.benzinga.com/pressreleases/20/09/g17499025/hexo-corp-announces-new-cfo,https://j.mp/2ZDuk9o
